Perlmutter Cancer Center - 38th Street — New York, New York

Perlmutter Cancer Center - 38th Street is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Perlmutter Cancer Center - 38th Street has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Advanced Upper Gastrointestinal Tract Adenocarcinoma, Platinum-resistant Ovarian Cancer, Light Chain (AL) Amyloidosis.

Sponsors: Arcus Biosciences, Inc., Genmab, Prothena Biosciences Ltd..

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perlmutter Cancer Center - 38th Street?

Perlmutter Cancer Center - 38th Street has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perlmutter Cancer Center - 38th Street conducted?

Perlmutter Cancer Center - 38th Street has 3 clinical trials on record, with 2 currently active. Their work covers Advanced Upper Gastrointestinal Tract Adenocarcinoma, Platinum-resistant Ovarian Cancer, Light Chain (AL) Amyloidosis.

Is Perlmutter Cancer Center - 38th Street accredited by Crixeo Health?

Perlmutter Cancer Center - 38th Street has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Perlmutter Cancer Center - 38th Street?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.